Search Results - "Maschi, C."

Clinical features, diagnosis, treatment, and course of ocular sarcoidosis with or without uveitis: A retrospective, comparative study by Ngo, L.C., Nahon-Estève, S., Maschi, C., Martel, A., Lassalle, S., Tieulie, N., Baillif, S.

“…To evaluate and compare characteristics, diagnosis, treatment, visual prognosis, and course between ocular sarcoidosis with or without uveitis in a population…”
Get full text

Pain after tonsillectomy: effectiveness of current guidelines? by Walrave, Y., Maschi, C., Bailleux, S., Falk, A. T., Hayem, C., Carles, M., De la Brière, F.

“…Background Tonsillectomy is one of the most common major surgical procedures performed in children. In 2013, the use of codeine in children was severely…”
Get full text

Data Summarization in the Node by Parameters (DSNP): Local Data Fusion in an IoT Environment by Maschi, Luis F C, Pinto, Alex S R, Meneguette, Rodolfo I, Baldassin, Alexandro

“…With the advent of the Internet of Things, billions of objects or devices are inserted into the global computer network, generating and processing data at a…”
Get full text

Impact of COVID-19 on uveal melanoma in France by Hamerstehl, A., Gadiollet, É., Martel, A., Groulier, A., Aloi, D., Nguyen, A.M., Lassalle, S., Bertolotto, C., Caujolle, J.-P., Maschi, C., Ducoulombier, A., Mathis, T., Baillif, S., Nahon-Estève, S.

“…Treatment delays due to the COVID-19 pandemic in uveal melanoma (UM) patients have led to an increased rate of enucleations in Europe. The impact of multiple…”
Get full text

Management of choroidal metastases by Jardel, P, Sauerwein, W, Olivier, T, Bensoussan, E, Maschi, C, Lanza, F, Mosci, C, Gastaud, L, Angellier, G, Marcy, P.-Y, Herault, J, Caujolle, J.-P, Dendale, R, Thariat, J

“…Highlights • Choroidal metastases are the most frequent malignant tumors of the eye. • They can lead to severe complications (such as blindness) and…”
Get full text

Phosphenes Under Proton therapy for Eye Tumors by Thariat, J.O, Loreti, G, Maschi, C, Caujolle, J.P, Herault, J

Get full text

Tumour Response in Uveal Melanomas Treated with Proton Beam Therapy by Maschi, C, Thariat, J, Herault, J, Caujolle, J.-P

“…Abstract Aims Post-proton therapy surveillance of uveal melanomas relies on decreased thickness on repeat ultrasound B every 6 months for 2 years and yearly…”
Get full text

Dexamethasone 0.7‐mg intravitreal implant in patients with radiation macular edema after proton beam therapy for choroidal melanoma: 2‐year results by Baillif, S., Maschi, C., Caujolle, J.P.

“…Purpose To evaluate over a 2‐year period, the efficacy of dexamethasone 0.7‐mg intravitreal implant in patients with radiation macular edema after proton beam…”
Get full text

Local, regional and systemic dissemination of choroidal melanoma : Clinical and pathological correlation from 2 cases by Martel, A, Lassalle, S, Gastaud, L, Maschi, C, Caujolle, J P, Nahon-Esteve, S

“…To describe didactically the local, regional and systemic spread of choroidal melanoma. Two patients who had undergone primary enucleation for the management…”
Get more information

Mascara deposits in an anophthalmic socket mimicking a conjunctival melanoma by Martel, A., Caujolle, J.P., Baillif, S., Maschi, C., Lassalle, S., Nahon-Esteve, S.

Get full text

Treatment of circumscribed choroidal haemangioma in 2015 by Maschi, C., Thariat, J., Baillif, S., Caujolle, J.P.

“…Purpose To assess local control and visual outcomes in patients treated for circumscribed choroidal hemangiomas either by photodynamic therapy (PDT) or proton…”
Get full text

Outcomes after proton beam therapy for large choroidal melanomas in 492 patients by Bensoussan, E., Baillif, S., Maschi, C., Caujolle, J.P., Thariat, J.

“…Purpose To evaluate proton beam therapy (PBT) as a mean to preserve the eye and spare some vision while not deteriorating survival in patients with large…”
Get full text

OC-0245: Protontherapy for uveal melanomas of temporal superior by Lanteri, S, Maschi, C, Herault, J, Angellier, G, Peyrichon, M, Baillif, S, Thariat, J, Caujolle, J

Get full text

EP-1464: Protontherapy or photodynamic therapy in the treatment of circumscribed choroidal haemangiomas by Thariat, J, Maschi, C, Franceschetti, C, Baillif, S, Angellier, G, Peyrichon, M, Herault, J, Caujolle, J

Get full text

Dry eye syndrome following proton therapy of ocular melanomas by Maschi, C., Sara, L., Peyrichon, M.L., Baillif, S., Herault, J., Thariat, J., Caujolle, J.P.

“…Purpose Some institutions contra‐indicate proton therapy (PT) for ocular melanomas of temporal superior location (TS) owing to lacrimal gland irradiation and…”
Get full text

OC-0246: Visual outcomes of parapapillary uveal melanomas following proton beam therapy by Thariat, J, Grange, J, Mosci, C, Rosier, L, Maschi, C, Lanza, F, Nguyen, A, Jaspart, F, Bacin, F, Bonnin, M, Gaucher, D, Sauerwein, W, Angellier, G, Peyrichon, M, Herault, J, Caujolle, J

Get full text

Malignant tumours of the eye: Epidemiology, diagnostic methods and radiotherapy by Jardel, P, Caujolle, J-P, Gastaud, L, Maschi, C, Sauerwein, W, Thariat, J

“…Malignant tumours of the eye are not common, barely representing 1 % of all cancers. This article aims to summarise, for each of the main eye malignant…”
Get full text

Benign conjunctival tumors by Maschi, C, Caujolle, J-P, Liolios, I, Costet, C

“…Benign conjunctival tumors include congenital, melanocytic, epithelial and stromal lesions. Clinical observation often fails to make the diagnosis, and…”
Get more information

Tumeurs conjonctivales bénignes by Maschi, C., Caujolle, J.-P., Liolios, I., Costet, C.

“…Les tumeurs bénignes conjonctivales regroupent les lésions congénitales, les lésions mélanocytaires, les lésions épithéliales et les lésions stromales. Leur…”
Get full text

Surgery and additional protontherapy for treatment of invasive and recurrent squamous cell carcinomas: technique and preliminary results by Caujolle, J-P, Maschi, C, Chauvel, P, Herault, J, Gastaud, P

“…Invasive squamous cell carcinomas are uncommon neoplasias with high recurrence and mortality rates. The improvement of tumoral control requires additional…”
Get more information